论文部分内容阅读
目的:探讨红花黄色素治疗急性脑梗死的临床疗效。方法:选取急性脑梗死患者80例,随机分为对照组和观察组各40例。对照组采用常规治疗方案治疗,观察组在对照组的基础上加用红花黄色素治疗。观察比较两组患者的临床治疗效果以及不良反应发生情况。结果:观察组患者总有效率为92.5%,明显高于对照组的80.0%,两组比较差异具有统计学意义(P<0.05);两组患者治疗前NIHSS评分差异无统计学意义(P>0.05),治疗后两组患者均有所改善,观察组患者治疗7天、治疗14天后的NIHSS评分均明显优于对照组,差异均具有统计学意义(P均<0.05);两组患者不良反应发生情况比较差异无统计学意义(P>0.05)。结论:红花黄色素结合常规治疗急性脑梗死疗效更佳,可显著改善患者的神经功能缺损情况,且不良反应发生率低,值得临床推广应用。
Objective: To investigate the clinical efficacy of safflor yellow in the treatment of acute cerebral infarction. Methods: A total of 80 acute cerebral infarction patients were selected and randomly divided into control group and observation group of 40 cases. The control group was treated with routine treatment. The observation group was treated with safflower yellow on the basis of the control group. The clinical effects and adverse reactions of two groups were observed and compared. Results: The total effective rate in the observation group was 92.5%, which was significantly higher than that in the control group (80.0%, P <0.05). There was no significant difference in NIHSS score between the two groups before treatment (P> 0.05). After treatment, the patients in both groups improved. In the observation group, the NIHSS scores of 7 days after treatment and 14 days after treatment were significantly better than those of the control group (all P <0.05) There was no significant difference in response (P> 0.05). Conclusion: Safflower yellow combined with conventional treatment of acute cerebral infarction better efficacy, can significantly improve the patient’s neurological deficit, and the incidence of adverse reactions is low, worthy of clinical application.